David Monteith

David Monteith is a declared insider of Avadel Pharmaceuticals PLC, with filings sourced from SEC (Form 4). We count 6 filings; the first trade dates from 10 August 2016 and the latest from 3 January 2017.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 13 January 2017 came the latest disclosure, a share grant in Avadel Pharmaceuticals PLC. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.